About
2breathe Technologies Ltd. and its founders are pioneers in the development of the digital therapeutic devices field, first in hypertension and now in sleeplessness. The original product, RESPeRATE® (www.resperate.com), is the world's first FDA-cleared, non-drug hypertension treatment device now used by hundreds of thousands of patients is featured in the American Heart Association statement on non-pharmacological treatments. The new product, 2breathe™, adopts RESPeRATE guided-breathing technology for individuals who have difficulties falling asleep. 2breathe is not a medical device and is not intended to diagnose or treat medical conditions.
Technologies
Cloudflare DNSElasticEmailGmailGoogle AppsCloudFlare HostingMailchimp MandrillStripeZoho SalesIQFacebook Custom AudiencesGoogle Tag ManagerWoo CommerceMobile FriendlyKlarnaWordPress.orgFacebook Login (Connect)Google RemarketingGoogle Dynamic RemarketingDoubleClick ConversionFacebook WidgetGoogle Analytics
Keywords
hypertensiondigital theraputic devicessleepheart healthsympathetic nervous activitynon-drug treatmentdevice for chronic hypertensionnon-invasive deviceexhalation prolongationmeditation alternativedevice-guided breathingbreathing therapymicrocirculation improvementtherapeutic breathingstress reductionarterial resistance reductionbreathing rhythm therapyvascular healthhypertension managementfda clearedself-carebreathing sensor beltmedical devicehypertension therapyblood vessel relaxationhealthtechmedical devicesblood pressure monitormedical equipment and supplies manufacturinghome blood pressure control
Company Information
- Employees7
- Annual Revenue$30000000
Location
Tel Aviv-Yafo, Tel Aviv District, Israel, 60000